Literature DB >> 2344174

Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

C Betriu1, E Campos, C Cabronero, C Rodriguez-Avial, J J Picazo.   

Abstract

A total of 94 clinical isolates of the Bacteroides fragilis group was tested for susceptibility to metronidazole, chloramphenicol, clindamycin, cefoxitin, cefotetan, cefmetazole, moxalactam, mezlocillin, amoxicillin-clavulanic acid, and imipenem. All the strains tested were susceptible to imipenem, metronidazole, amoxicillin-clavulanic acid, and chloramphenicol. The rate of resistance to clindamycin was 21%. The results of this study demonstrate a difference in resistance rates from one species of the B. fragilis group to another.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2344174      PMCID： PMC171666          DOI： 10.1128/AAC.34.4.671

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  Bacteroides fragilis resistant to both metronidazole and imipenem.

Authors:  F Lamothe; C Fijalkowski; F Malouin; A M Bourgault; L Delorme
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

2.  Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.

Authors:  A E De Almeida; M De Uzeda
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

3.  The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.

Authors:  E M Brown
Journal:  J Antimicrob Chemother       Date:  1984-10       Impact factor: 5.790

4.  In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.

Authors:  A M Bourgault; F Lamothe
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

5.  Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Authors:  G J Cuchural; F P Tally; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Survey of anaerobic susceptibility patterns in Canada.

Authors:  A M Bourgault; G K Harding; J A Smith; G B Horsman; T J Marrie; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.

Authors:  F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

9.  Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

Authors:  G J Cuchural; M H Malamy; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  In vitro activity of cefbuperazone against Bacteroides spp.

Authors:  M B Dias; N V Jacobus; S L Gorbach; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191
View more
  11 in total

1.  Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.

Authors:  I Phillips; A King; C E Nord; B Hoffstedt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

2.  Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.

Authors:  R Horn; J Lavallée; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

3.  In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.

Authors:  K Lee; I H Jang; Y J Kim; Y Chong
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 4.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

5.  Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Authors:  L Dubreuil; J Breuil; A Dublanchet; A Sedallian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

6.  In vitro susceptibility to selected antibiotics in bacteria of the Bacteroides fragilis group.

Authors:  D Chmelar
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

7.  Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.

Authors:  P Mastrantonio; P Spigaglia; A Sebastianelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

8.  Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.

Authors:  C Betriu; C Cabronero; M Gomez; J J Picazo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

9.  In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp.

Authors:  S L Pendland; S C Piscitelli; P C Schreckenberger; L H Danziger
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 10.  Resistance of anaerobic bacteria to antimicrobial agents in Spain.

Authors:  F Baquero; M Reig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.